合同物流领域的市场、德国邮政 DHL 集团的一部分 DHL Supply Chain 将再次代表生命科学和医疗保健行业的供应链会议 LogiPharma。在瑞士蒙特勒为期 3 天的活动中，800 多位国际医药供应链专家正在讨论医药物流、和规划的未来，以及数字化、客户至上的解决方案和改进的端到端解决方案的战略在快速变化的生命科学和医疗保健行业中的度。
“制药供应链中的决策者面临着越来越多的挑战，他们必须围绕改善服务和提供更多以客户和患者为中心的解决方案做出权衡决策，同时需要削减成本、减少库存以及差异化的市场和新地域路线。与此同时，新技术、个性化药物和先进疗法不断创造新的、甚至更复杂的供应链”，DHL 欧洲大陆和中东供应链副总裁兼生命科学与医疗保健业务发展负责人 Paolo Rosanna 说和非洲，在今年的 LogiPharma 期间。
“因此，我们必须与制药行业的客户密切合作，并建立新的综合方法。医药物流的未来将比今天更加以患者为中心，这需要更复杂的端到端供应链解决方案。这就是数字化和自动化发挥作用的地方。新技术的实施——从可穿戴设备到机器人流程自动化和人工智能——有助于改善信息流、优化库存水平和缩短订单时间”，DHL 德国和阿尔卑斯地区供应链执行官 Karsten Schwarz 说，他负责DHL 供应链欧洲委员会的生命科学和医疗保健部门。
“我们的客户可以期望我们对这些解决方案有充分的了解，我们选择正确的技术和方法，并为公司和患者提供的合同物流服务。但所有物流公司都需要不断发展，将创新和新技术带到桌面上，创造更多价值。仅仅复制实践以跟上这些新趋势带来的加速发展的步伐已经不够了”，DHL 欧洲大陆、中东和非洲供应链副总裁兼生命科学与医疗保健业务发展主管 Paolo Rosanna ，在今年的 LogiPharma 期间。
This year, DHL Supply Chain, market leader in contract logistics and part of the Deutsche Post DHL Group, will once again be represented at LogiPharma, the leading supply chain conference for the Life Science and Health Care industry. During this 3-day event in Montreux, Switzerland, over 800 international pharma supply chain experts are discussing the future of pharma logistics, distribution and planning, as well as the latest strategies for digitalization, customer-first solutions and improved end-to-end visibility in the fast changing Life Science and Health Care industry.
“Decision makers in pharmaceutic supply chains are increasingly challenged to make trade off decisions around improving services and providing more customer and patient-centric solutions, while at the same time cost cuts, reduced inventories and differentiated routes to markets and new geographies are demanded. At the same time new technologies, personalized medicines and advanced therapies are constantly creating new and even more complex supply chains”, says Paolo Rosanna, Vice President and Head of Business Development Life Sciences & Healthcare, at DHL Supply Chain for Mainland Europe, Middle East and Africa, during this year’s LogiPharma.
“Therefore it is imperative for us to work very closely with our customers in the pharma industry and establish new and integrated approaches. The future of pharma logistics is all about being even more patient-centric than today, which requires more sophisticated end-to-end supply chain solutions. This is where digitalization and automation comes into play. The implementation of new technologies - from wearables to robotic process automation and artificial intelligence - can help to improve the flow of information, optimize stock levels and improve order times“, says Karsten Schwarz, CEO DHL Supply Chain for Germany & Alps and responsible for the Life-Science and Health Care sector in the European Board of DHL Supply Chain.